SHEILA EASTMOND-CHAPMAN: Open Payments
NPI 1669994497 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 22 payments from 7 companies in 2025. Trend: 2023 $175 · 2024 $69 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $329 |
| E.R. Squibb & Sons, L.L.C. | 2 | $145 |
| Janssen Pharmaceuticals, Inc | 3 | $108 |
| Braeburn Inc. | 4 | $88 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Indivior Inc. | 1 | $29 |
| Orexo US, Inc. | 1 | $17 |
Products named: VIVITROL, COBENFY, SPRAVATO, BRIXADI, UZEDY, SUBLOCADE, Zubsolv.
Industry payments across NY — which companies pay providers there.
